<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
<url>
<loc>https://pathwayinpeptides.com</loc>
<lastmod>2026-11-17T18:22:57.214Z</lastmod>
<changefreq>daily</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/sections/nose-to-brain-delivery</loc>
<lastmod>2026-11-12T16:17:22.236Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/sections/glp-1-biology</loc>
<lastmod>2026-10-14T15:22:32.685Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/sections/nanomedicine-platforms</loc>
<lastmod>2026-11-17T18:22:57.214Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/sections/glp-1-neurology</loc>
<lastmod>2026-09-30T18:40:20.539Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/authors/vikram-nandakumar</loc>
<lastmod>2026-11-17T18:22:57.214Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.4</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/authors/miriam-osei-bonsu</loc>
<lastmod>2026-11-17T18:22:57.214Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.4</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/authors/rafael-trevi-o-mares</loc>
<lastmod>2026-11-17T18:22:57.214Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.4</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/authors/saoirse-dunleavy</loc>
<lastmod>2026-11-17T18:22:57.214Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.4</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/why-peptide-delivery-platform-depth-is-measured-in-foundational-patents-not-publ</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/43d9330d-2b6e-472b-ac28-10c0fe1deba8.jpeg</image:loc>
</image:image>
<lastmod>2026-11-17T18:22:57.214Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/how-neurological-indication-strategy-separates-serious-nose-to-brain-nanoparticl</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/ff0f92f7-889e-4cb5-ba3f-84f213c288a9.jpeg</image:loc>
</image:image>
<lastmod>2026-11-16T16:32:53.452Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/olfactory-route-peptide-kinetics-versus-iv-in-deep-brain-structures-what-the-con</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/cea406ad-a7af-4101-935c-fd40c954c086.jpeg</image:loc>
</image:image>
<lastmod>2026-11-13T17:43:31.826Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/nose-to-brain-versus-iv-and-intrathecal-routes-scored-against-the-clinical-and-r</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/8d449bd9-546a-4e6a-b4bf-131539a6147b.jpeg</image:loc>
</image:image>
<lastmod>2026-11-12T16:17:22.236Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/thirty-years-of-nanoparticle-patent-prosecution-and-what-olfactory-cns-claim-con</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/793d1a7e-6889-4361-94d0-5504534cd948.jpeg</image:loc>
</image:image>
<lastmod>2026-11-11T17:17:06.304Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/pipeline-architecture-of-early-stage-intranasal-cns-peptide-companies-built-arou</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/6ebdfd7d-199c-4b73-a2e6-4feb80d73588.jpeg</image:loc>
</image:image>
<lastmod>2026-11-10T17:02:15.461Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/non-injection-bbb-bypass-platforms-evaluated-against-peptide-therapeutic-require</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/1dd22205-be16-4063-9c2d-8159bee8e505.jpeg</image:loc>
</image:image>
<lastmod>2026-11-09T17:02:31.629Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/matching-nanoparticle-platform-architecture-to-peptide-biologic-cargo-for-intran</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/4c8c52e8-c608-495c-8807-bb6f0a64c177.jpeg</image:loc>
</image:image>
<lastmod>2026-11-07T17:16:59.511Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/nose-to-brain-cns-startups-ranked-by-nanoparticle-platform-provenance-and-peptid</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/a8aa3e80-13e3-4aae-bc77-57a161369cb0.jpeg</image:loc>
</image:image>
<lastmod>2026-11-05T17:02:17.377Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/peptide-conformation-preservation-from-nasal-mucosa-to-cns-target-site</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/12935c0b-8043-4e1a-a69e-69d3a87fe8c9.jpeg</image:loc>
</image:image>
<lastmod>2026-11-04T16:36:23.897Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/nanoparticle-architecture-for-mucosal-peptide-delivery</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/7f3292b4-403d-409b-b969-ecbf26b55e0f.jpeg</image:loc>
</image:image>
<lastmod>2026-11-03T17:22:24.823Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/approved-intranasal-cns-drugs-as-proof-of-concept</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/a496deda-6994-4423-96cc-c21df480ed39.jpeg</image:loc>
</image:image>
<lastmod>2026-10-31T15:11:10.964Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/preclinical-models-for-nose-to-brain-pharmacokinetic-studies</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/e647dd92-1b1c-4af3-96f7-742a91a183e1.jpeg</image:loc>
</image:image>
<lastmod>2026-10-28T15:52:12.602Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/early-stage-companies-pairing-nanoparticle-formulation-ip-with-intranasal-peptid</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/5522df9e-69b0-46dd-b368-d8cd6d47226c.jpeg</image:loc>
</image:image>
<lastmod>2026-10-27T16:46:52.181Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/companies-developing-intranasal-biologics-and-peptide-therapeutics</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/a2c2610b-8ff0-4df8-a6da-fe626d0da35c.jpeg</image:loc>
</image:image>
<lastmod>2026-10-24T16:55:58.342Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/blood-brain-barrier-bypass-via-the-nasal-route</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/5fa30397-e830-4774-aa0d-3120ab0523f8.jpeg</image:loc>
</image:image>
<lastmod>2026-10-23T16:31:51.813Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/mucociliary-clearance-and-nasal-residence-time-optimization</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/831c5bf9-5f4f-49a6-a6fb-1b7778ae1d68.jpeg</image:loc>
</image:image>
<lastmod>2026-10-21T17:22:09.837Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/intranasal-delivery-of-large-molecule-biologics-and-peptides</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/6a08c7e4-7cf2-4378-9f43-e8f52157ef0b.jpeg</image:loc>
</image:image>
<lastmod>2026-10-17T15:55:50.980Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/olfactory-epithelium-anatomy-and-drug-transport-pathways</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/eed1e44a-3779-49d2-b932-f027970aadfc.jpeg</image:loc>
</image:image>
<lastmod>2026-10-15T15:21:24.208Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/cardiovascular-benefits-of-glp-1-agonists-beyond-glycemic-control</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/cd009bf3-c6de-4959-be51-e47e895ca5c7.jpeg</image:loc>
</image:image>
<lastmod>2026-10-14T15:22:32.685Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/emerging-glp-1-indications-beyond-obesity-and-diabetes</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/deb56604-785c-4ba5-9dc7-0670bc435cdf.jpeg</image:loc>
</image:image>
<lastmod>2026-10-13T16:32:22.711Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/tirzepatide-vs-semaglutide-as-dual-and-single-agonist-platforms</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/cbc5219e-88b2-4b26-af6b-546d63d84943.jpeg</image:loc>
</image:image>
<lastmod>2026-10-09T16:35:10.640Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/peptide-half-life-engineering-in-glp-1-analogs</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/afe2156f-d5f6-422a-97a7-4bb7bbcf0952.jpeg</image:loc>
</image:image>
<lastmod>2026-10-08T15:21:17.677Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/glp-1-peptide-degradation-pathways-and-stability-challenges</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/b2faa4fb-1d59-4f10-ac1d-6f52f4cc314e.jpeg</image:loc>
</image:image>
<lastmod>2026-10-07T17:20:44.077Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/glp-1-agonist-dropout-rates-and-adherence-data</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/0157d5d1-5138-4110-b86a-e6d35ea76ca1.png</image:loc>
</image:image>
<lastmod>2026-10-06T16:05:31.012Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/mechanisms-behind-glp-1-nausea-and-vomiting</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/2a3500a8-54c1-4424-b70d-b7aafd22df9a.png</image:loc>
</image:image>
<lastmod>2026-10-05T17:00:41.980Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/glp-1-market-size-key-players-and-the-race-to-solve-compliance</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/e50ccfb3-4298-4797-a71e-b4bc05fc8a46.jpeg</image:loc>
</image:image>
<lastmod>2026-10-02T15:06:44.177Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/glp-1-receptor-distribution-in-the-brain-and-gut</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/f0fa2f64-aff4-4649-98e1-c15f3db6fc6a.jpeg</image:loc>
</image:image>
<lastmod>2026-10-01T16:25:38.791Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://pathwayinpeptides.com/posts/preclinical-evidence-for-glp-1-agonists-in-alcohol-use-disorder</loc>
<image:image>
<image:loc>https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/914267c5-b8c2-4464-8dfb-91cb3621922b/generated/3a226c8f-1207-4991-9d55-341257fd1774.jpeg</image:loc>
</image:image>
<lastmod>2026-09-30T18:40:20.539Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
</urlset>
